Sarah Goldberg, MD, MPH, Yale Cancer Center/Smilow Cancer Hospital

Best of ASCO - 07/18/23 - Lung Cancer Living RoomПодробнее

Dr. Goldberg on Treatment Strategies for CNS MetastasesПодробнее

Dr. Goldberg on Immune/Targeted Therapy Combos in Oncogene-Driven Lung CancerПодробнее

Dr. Goldberg on Managing CNS Metastases in Oncogene-Driven NSCLCПодробнее

Considering the Role of Clinical Trials for Patients With Molecularly Altered Lung CancersПодробнее

Smilow Shares Primary Care: Lung CancerПодробнее

Dr. Goldberg Discusses the Diagnosis of MesotheliomaПодробнее

Considering the Role of Clinical Trials for Patients With Molecularly-Altered Lung CancerПодробнее

Dr. Goldberg Discusses Treatment Approaches for MesotheliomaПодробнее

Dr. Goldberg on PD-L1 as a Biomarker in Lung CancerПодробнее

Treating NSCLC Patients Without an Actionable Oncogenic DriverПодробнее

Dr. Goldberg on Further Immunotherapy Trials in Non-Small Cell Lung CancerПодробнее

Dr. Goldberg on Options After Developing Resistance to Osimertinib for NSCLCПодробнее

The Lung Cancer Living Room™ - Yale University - Nov. 2, 2017 - Full 2-Hour EpisodeПодробнее

Dr. Goldberg on Resistance to Osimertinib for NSCLCПодробнее

Sarah B. Goldberg Discusses New Immunotherapy Options for Patients With Lung CancerПодробнее

Sarah B. Goldberg on the Side Effects of ImmunotherapyПодробнее